🇺🇸 Acetaminophen, Gabapentin in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 8

Most-reported reactions

1. Abnormal Loss Of Weight — 1 report (12.5%)
2. Cervical Vertebral Fracture — 1 report (12.5%)
3. Fall — 1 report (12.5%)
4. Fluid Retention — 1 report (12.5%)
5. Gait Inability — 1 report (12.5%)
6. Gout — 1 report (12.5%)
7. Urinary Tract Infection — 1 report (12.5%)
8. Weight Increased — 1 report (12.5%)

Source database →

Frequently asked questions

Is Acetaminophen, Gabapentin approved in United States?

Acetaminophen, Gabapentin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Acetaminophen, Gabapentin in United States?

University of Saskatchewan is the originator. The local marketing authorisation holder may differ — check the official source linked above.